Else Nutrition
Graphite One

Bunge Reports Third Quarter 2021 Results 

  • Increasing full-year adjusted EPS outlook to at least $11.50 based on strong Q3 results and favorable market trends
  • Repurchased $100 million of Bunge common shares completing existing $500 million authorization; Bunge Board authorized new $500 million program
  • Announced actions to further improve business portfolio: forming renewable fuel feedstocks JV with Chevron and sale of Mexico wheat mills
  • Refined and Specialty Oils performance improved in all regions with particular strength in North America
  • Agribusiness results driven by strong execution and better than expected market environment
  • Strong performances across Bunge’s core and non-core operations
  • Q3 GAAP EPS of $4.28 vs. $1.84 in the prior year; $3.72 vs. $2.47 on an adjusted basis excluding certain gains/charges and mark-to-market timing differences

Bunge Limited (NYSE:BG) today reported third quarter 2021 results

Overview

Greg Heckman, Bunge's Chief Executive Officer, commented, “We delivered a truly exceptional quarter. Our team was nimble, insightful and proactive, effectively managing supply chains, capacity and risk. Our global platform has allowed us to serve our customers - both farmers and end consumers - in today's volatile environment. At the same time, we remain intensely focused on a disciplined and balanced approach to allocating capital to maintain our financial strength, invest in growth opportunities, and return capital to our shareholders.

“Looking ahead, we expect the favorable market trends to continue. We are well-positioned to help our customers across the supply chain address the challenges in meeting increasing consumer demand for sustainable food, feed and fuel.”

Financial Highlights

      

    Quarter Ended
    September 30,

     

    Nine Months Ended
    September 30,

    (US$ in millions, except per share data)

     

    2021

     

    2020

     

    2021

     

    2020

    Net income attributable to Bunge

     

    $

    653

     

     

     

    $

    262

     

     

     

    $

    1,847

     

     

     

    $

    594

     

     

     

     

     

     

     

     

     

     

    Net income per common share-diluted

     

    $

    4.28

     

     

     

    $

    1.84

     

     

     

    $

    12.12

     

     

     

    $

    3.98

     

     

     

     

     

     

     

     

     

     

    Mark-to-market timing difference (a)

     

    $

    0.22

     

     

     

    $

    0.85

     

     

     

    $

    (0.83

    )

     

     

    $

    0.97

     

    Certain (gains) and charges (b)

     

    $

    (0.78

    )

     

     

    $

    (0.14

    )

     

     

    $

    (1.86

    )

     

     

    $

    0.32

     

    Adjustment of redeemable noncontrolling interest (c)

     

    $

     

     

     

    $

    (0.08

    )

     

     

    $

     

     

     

    $

    (0.01

    )

    Adjusted Net income per common share-diluted (d)

     

    $

    3.72

     

     

     

    $

    2.47

     

     

     

    $

    9.43

     

     

     

    $

    5.26

     

     

     

     

     

     

     

     

     

     

    Core Segment EBIT (d) (e)

     

    $

    812

     

     

     

    $

    419

     

     

     

    $

    2,464

     

     

     

    $

    1,312

     

    Mark-to-market timing difference (a)

     

    44

     

     

     

    161

     

     

     

    (151

    )

     

     

    186

     

    Certain (gains) & charges (b)

     

    (158

    )

     

     

     

     

     

    (328

    )

     

     

     

    Adjusted Core Segment EBIT (d)

     

    $

    698

     

     

     

    $

    580

     

     

     

    $

    1,985

     

     

     

    $

    1,498

     

     

     

     

     

     

     

     

     

     

    Corporate and Other EBIT (d)

     

    $

    (81

    )

     

     

    $

    (92

    )

     

     

    $

    (227

    )

     

     

    $

    (279

    )

    Certain (gains) & charges (b)

     

     

     

     

     

     

     

     

     

     

    71

     

    Adjusted Corporate and Other EBIT (d)

     

    $

    (81

    )

     

     

    $

    (92

    )

     

     

    $

    (227

    )

     

     

    $

    (208

    )

     

     

     

     

     

     

     

     

     

    Non-core Segment EBIT (d) (f)

     

    $

    53

     

     

     

    $

    24

     

     

     

    $

    92

     

     

     

    $

    (114

    )

    Certain (gains) & charges (b)

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Non-core Segment EBIT (d)

     

    $

    53

     

     

     

    $

    24

     

     

     

    $

    92

     

     

     

    $

    (114

    )

     

     

     

     

     

     

     

     

     

    Total Segment EBIT (d)

     

    $

    784

     

     

     

    $

    351

     

     

     

    $

    2,329

     

     

     

    $

    919

     

    Mark-to-market timing difference (a)

     

    44

     

     

     

    $

    161

     

     

     

    $

    (151

    )

     

     

    $

    186

     

    Total Certain (gains) & charges (b)

     

    (158

    )

     

     

    $

     

     

     

    $

    (328

    )

     

     

    $

    71

     

    Adjusted Total Segment EBIT (d)

     

    $

    670

     

     

     

    $

    512

     

     

     

    $

    1,850

     

     

     

    $

    1,176

     

    (a)

     

    Mark-to-market timing impact of certain commodity and freight contracts, readily marketable inventories, and related hedges associated with committed future operating capacity. See note 3 in the Additional Financial information section of this release for details.

    (b)

     

    Certain (gains) & charges included in Total Segment EBIT. See Additional Financial Information for details.

    (c)

     

    Retained earnings impact associated with an adjustment to the carrying amount of the redeemable noncontrolling interest recorded in respect of our 70% ownership interest in Loders. See note 4 in the Additional Financial information section of this release for details.

    (d)

     

    Core Segment EBIT, Adjusted Core Segment EBIT, Corporate and Other EBIT, Adjusted Corporate and Other EBIT, Non-core Segment EBIT, Adjusted Non-core Segment EBIT, Total Segment EBIT, Adjusted Total Segment EBIT, and Adjusted Net income per common share-diluted are non-GAAP financial measures. Reconciliations to the most directly comparable U.S. GAAP measures are included in the tables attached to this press release and the accompanying slide presentation posted on Bunge's website.

    (e)

     

    Core Segment earnings before interest and tax ("Core Segment EBIT") comprises the aggregate earnings before interest and tax (“EBIT”) of Bunge’s Agribusiness, Refined and Specialty Oils and Milling reportable segments, and excludes Bunge's Sugar & Bioenergy reportable segment and Corporate and Other activities.

    (f)

     

    Non-core Segment EBIT comprises Bunge’s Sugar & Bioenergy reportable segment EBIT, which reflects Bunge's share of the results of its 50/50 joint venture with BP p.l.c.

    Third Quarter Results

    Core Segments

    Agribusiness

       

      Quarter Ended

       

      Nine Months Ended

      (US$ in millions, except per share data)

      Sep 30, 2021

       

      Sep 30, 2020

       

      Sep 30, 2021

       

      Sep 30, 2020

      Volumes (in thousand metric tons)

      30,486

       

       

      36,319

       

       

      106,375

       

       

      107,269

       

       

       

       

       

       

       

       

       

      Net Sales

      $

      9,868

       

       

      $

      7,290

       

       

      $

      31,312

       

       

      $

      20,597

       

       

       

       

       

       

       

       

       

      Gross Profit

      $

      591

       

       

      $

      373

       

       

      $

      1,887

       

       

      $

      1,278

       

       

       

       

       

       

       

       

       

      Selling, general and administrative expense

      $

      (118

      )

       

      $

      (145

      )

       

      $

      (313

      )

       

      $

      (365

      )

       

       

       

       

       

       

       

       

      Foreign exchange gains (losses)

      $

      (30

      )

       

      $

      59

       

       

      $

      (1

      )

       

      $

      78

       

       

       

       

       

       

       

       

       

      EBIT attributable to noncontrolling interests

      $

      5

       

       

      $

      (2

      )

       

      $

      (6

      )

       

      $

      (7

      )

       

       

       

       

       

       

       

       

      Other income (expense) - net

      $

      181

       

       

      $

      15

       

       

      $

      227

       

       

      $

      39

       

       

       

       

       

       

       

       

       

      Income (loss) from affiliates

      $

      10

       

       

      $

      17

       

       

      $

      44

       

       

      $

      46

       

       

       

       

       

       

       

       

       

      Segment EBIT

      $

      639

       

       

      $

      317

       

       

      $

      1,838

       

       

      $

      1,069

       

      Mark-to-market timing difference

      52

       

       

      168

       

       

      (144

      )

       

      175

       

      Certain (gains) & charges

      (158

      )

       

       

       

      (158

      )

       

       

      Adjusted Segment EBIT

      $

      533

       

       

      $

      485

       

       

      $

      1,536

       

       

      $

      1,244

       

       

       

       

       

       

       

       

       

      Certain (gains) & charges, Net Income (Loss) Attributable to Bunge

      $

      (119

      )

       

      $

       

       

      $

      (119

      )

       

      $

       

      Certain (gains) & charges, Earnings Per Share

      $

      (0.78

      )

       

      $

       

       

      $

      (0.78

      )

       

      $

       

      Processing (2)

         

       

      Quarter Ended

       

      Nine Months Ended

      (US$ in millions)

      Sep 30, 2021

       

      Sep 30, 2020

       

      Sep 30, 2021

       

      Sep 30, 2020

      Processing EBIT

      $

      298

       

       

      $

      235

       

      $

      1,364

       

       

      $

      828

      Mark-to-market timing difference

      194

       

       

      178

       

      (301

      )

       

      141

      Certain (gains) & charges

      (73

      )

       

       

      (73

      )

       

      Adjusted Processing EBIT

      $

      419

       

       

      $

      413

       

      $

      990

       

       

      $

      969

      In Processing, higher results in North America, European softseeds and our Asian and European destination value chains, which all benefited from strong vegetable oil demand, were partially offset by lower results in South America, where margins were down compared to a particularly strong prior year.

      Merchandising (2)

         

       

      Quarter Ended

       

      Nine Months Ended

      (US$ in millions)

      Sep 30, 2021

       

      Sep 30, 2020

       

      Sep 30, 2021

       

      Sep 30, 2020

      Merchandising EBIT

      $

      341

       

       

      $

      82

       

       

      $

      474

       

       

      $

      241

      Mark-to-market timing difference

      (142

      )

       

      (10

      )

       

      157

       

       

      34

      Certain (gains) & charges

      (85

      )

       

       

       

      (85

      )

       

      Adjusted Merchandising EBIT

      $

      114

       

       

      $

      72

       

       

      $

      546

       

       

      $

      275

      In Merchandising, improved performance was primarily driven by higher results in ocean freight, due to strong execution, and our global vegetable oil value chain, which benefited from increased margins.

      Refined & Specialty Oils

         

       

      Quarter Ended

       

      Nine Months Ended

      (US$ in millions, except per share data)

      Sep 30, 2021

      Sep 30, 2020

       

      Sep 30, 2021

      Sep 30, 2020

      Volumes (in thousand metric tons)

      2,390

       

      2,475

       

       

      6,841

       

      7,115

       

       

       

       

       

       

       

      Net Sales

      $

      3,648

       

      $

      2,432

       

       

      $

      9,572

       

      $

      6,887

       

       

       

       

       

       

       

      Gross Profit

      $

      218

       

      $

      178

       

       

      $

      648

       

      $

      453

       

       

       

       

       

       

       

      Selling, general and administrative expense

      $

      (83)

       

      $

      (96)

       

       

      $

      (259)

       

      $

      (279)

       

       

       

       

       

       

       

      Foreign exchange gains (losses)

      $

      (1)

       

      $

      (2)

       

       

      $

      1

       

      $

       

       

       

       

       

       

       

      EBIT attributable to noncontrolling interests

      $

      (2)

       

      $

      (3)

       

       

      $

      (85)

       

      $

      3

       

       

       

       

       

       

       

      Other income (expense) - net

      $

      (2)

       

      $

      (1)

       

       

      $

      236

       

      $

      (3)

       

       

       

       

       

       

       

      Segment EBIT

      $

      130

       

      $

      76

       

       

      $

      541

       

      $

      174

       

      Mark-to-market timing difference

      12

       

      (9)

       

       

      9

       

      8

       

      Certain (gains) & charges

       

       

       

      (170)

       

       

      Adjusted Segment EBIT

      $

      142

       

      $

      67

       

       

      $

      380

       

      $

      182

       

       

       

       

       

       

       

      Certain (gains) & charges, Net Income (Loss) Attributable to Bunge

      $

       

      $

       

       

      $

      (165)

       

      $

       

      Certain (gains) & charges, Earnings Per Share

      $

       

      $

       

       

      $

      (1.08)

       

      $

       

      Refined & Specialty Oils Summary

      The strong performance in the quarter was primarily driven by higher margins and volumes in North America refining, which continued to benefit from a recovery in foodservice and increased demand from the renewable diesel sector. Higher margins in Europe driven by favorable product mix also contributed to the improved performance. Results in South America and Asia were slightly higher than last year.

      Milling

         

       

      Quarter Ended

       

      Nine Months Ended

      (US$ in millions, except per share data)

      Sep 30, 2021

       

      Sep 30, 2020

       

      Sep 30, 2021

       

      Sep 30, 2020

      Volumes (in thousand metric tons)

      1,542

       

       

      1,231

       

       

      4,789

       

       

      4,430

       

       

       

       

       

       

       

       

       

      Net Sales

      $

      530

       

       

      $

      388

       

       

      $

      1,392

       

       

      $

      1,185

       

       

       

       

       

       

       

       

       

      Gross Profit

      $

      70

       

       

      $

      50

       

       

      $

      161

       

       

      $

      149

       

       

       

       

       

       

       

       

       

      Selling, general and administrative expense

      $

      (25

      )

       

      $

      (24

      )

       

      $

      (73

      )

       

      $

      (77

      )

       

       

       

       

       

       

       

       

      Foreign exchange gains (losses)

      $

      (2

      )

       

      $

      1

       

       

      $

      (2

      )

       

      $

       

       

       

       

       

       

       

       

       

      Segment EBIT

      $

      43

       

       

      $

      26

       

       

      $

      85

       

       

      $

      69

       

      Mark-to-market timing difference

      (20

      )

       

      2

       

       

      (16

      )

       

      3

       

      Certain (gains) & charges

       

       

       

       

       

       

       

      Adjusted Segment EBIT

      $

      23

       

       

      $

      28

       

       

      $

      69

       

       

      $

      72

       

       

       

       

       

       

       

       

       

      Certain (gains) & charges, Net Income (Loss) Attributable to Bunge

      $

       

       

      $

       

       

      $

       

       

      $

       

      Certain (gains) & charges, Earnings Per Share

      $

       

       

      $

       

       

      $

       

       

      $

       

      Milling Summary

      Lower results in the quarter were driven by Brazil where higher volume was more than offset by lower margins and higher supply chain costs. Results in North America were comparable with last year.

      Corporate and Other

         

       

      Quarter Ended

       

      Nine Months Ended

      (US$ in millions, except per share data)

      Sep 30, 2021

       

      Sep 30, 2020

       

      Sep 30, 2021

       

      Sep 30, 2020

      Gross Profit

      $

      (19

      )

       

      $

      (4

      )

       

      $

      (25

      )

       

      $

      (6

      )

       

       

       

       

       

       

       

       

      Selling, general and administrative expense

      $

      (101

      )

       

      $

      (87

      )

       

      $

      (250

      )

       

      $

      (272

      )

       

       

       

       

       

       

       

       

      Foreign exchange gains (losses)

      $

      (3

      )

       

      $

      (4

      )

       

      $

      (9

      )

       

      $

      (3

      )

       

       

       

       

       

       

       

       

      Other income (expense) - net

      $

      41

       

       

      $

      3

       

       

      $

      55

       

       

      $

      2

       

       

       

       

       

       

       

       

       

      Segment EBIT

      $

      (81

      )

       

      $

      (92

      )

       

      $

      (227

      )

       

      $

      (279

      )

      Certain (gains) & charges

       

       

       

       

       

       

      71

       

      Adjusted Segment EBIT

      $

      (81

      )

       

      $

      (92

      )

       

      $

      (227

      )

       

      $

      (208

      )

       

       

       

       

       

       

       

       

      Certain (gains) & charges, Net Income (Loss) Attributable to Bunge

      $

       

       

      $

      (21

      )

       

      $

       

       

      $

      48

       

      Certain (gains) & charges, Earnings Per Share

      $

       

       

      $

      (0.14

      )

       

      $

       

       

      $

      0.32

       

      Corporate

         

       

      Quarter Ended

       

      Nine Months Ended

      (US$ in millions)

      Sep 30, 2021

       

      Sep 30, 2020

       

      Sep 30, 2021

       

      Sep 30, 2020

      Corporate EBIT

      $

      (114

      )

       

      $

      (93

      )

       

      $

      (270

      )

       

      $

      (223

      )

      Certain (gains) & charges

       

       

       

       

       

       

      5

       

      Adjusted Corporate EBIT

      $

      (114

      )

       

      $

      (93

      )

       

      $

      (270

      )

       

      $

      (218

      )

      Other

         

       

      Quarter Ended

       

      Nine Months Ended

      (US$ in millions)

      Sep 30, 2021

       

      Sep 30, 2020

       

      Sep 30, 2021

       

      Sep 30, 2020

      Other EBIT

      $

      33

       

      $

      1

       

      $

      43

       

      $

      (56

      )

      Certain (gains) & charges

       

       

       

      66

       

      Adjusted Other EBIT

      $

      33

       

      $

      1

       

      $

      43

       

      $

      10

       

      Corporate and Other Summary

      The increase in Corporate expenses during the quarter was primarily related to performance-based compensation accruals. The gain in Other was primarily related to our Bunge Venture’s investment in Benson Hill, which went public during the quarter.

      Non-core Segments

      Sugar & Bioenergy

         

       

      Quarter Ended

       

      Nine Months Ended

      (US$ in millions, except per share data)

      Sep 30, 2021

      Sep 30, 2020

       

      Sep 30, 2021

      Sep 30, 2020

      Volumes (in thousand metric tons)

      91

       

      95

       

       

      291

       

      244

       

       

       

       

       

       

       

      Net Sales

      $

      69

       

      $

      49

       

       

      $

      190

       

      $

      125

       

       

       

       

       

       

       

      Gross Profit

      $

      2

       

      $

      5

       

       

      $

      3

       

      $

      7

       

       

       

       

       

       

       

      Income (loss) from affiliates

      $

      51

       

      $

      19

       

       

      $

      89

       

      $

      (121

      )

       

       

       

       

       

       

      Segment EBIT

      $

      53

       

      $

      24

       

       

      $

      92

       

      $

      (114

      )

      Certain (gains) & charges

       

       

       

       

       

      Adjusted Segment EBIT

      $

      53

       

      $

      24

       

       

      $

      92

       

      $

      (114

      )

       

       

       

       

       

       

      Certain (gains) & charges, Net Income (Loss) Attributable to Bunge

      $

       

      $

       

       

      $

       

      $

       

      Certain (gains) & charges, Earnings Per Share

      $

       

      $

       

       

      $

       

      $

       

      Sugar & Bioenergy Summary

      Improved results in the quarter were primarily driven by higher prices and sales volumes of ethanol and sugar.

      Cash Flow

       

      Nine Months Ended

       

      Sep 30, 2021

       

      Sep 30, 2020

      Cash used for operating activities

      $

      (1,642

      )

       

      (2,128

      )

      Net proceeds from beneficial interest in securitized trade receivables

      3,255

       

       

      1,164

       

      Cash provided by (used for) operating activities, adjusted

      $

      1,613

       

       

      (964

      )

      Cash used for operations in the nine months ended September 30, 2021 was $1,642 million compared to cash used of $2,128 million in the same period last year. Adjusting for the net proceeds from beneficial interest in securitized trade receivables, cash provided from operating activities was $1,613 million compared with cash used for operating activities of $964 million in the prior year. Funds from operations (FFO) adjusted for notable items and mark-to-market timing differences was $1,304 million compared to $1,299 million in the prior year(5).

      Income Taxes

      For the nine months ended September 30, 2021, income tax expense was $334 million compared to $151 million for the prior year. The increase in income tax expense is due to higher pre-tax income, partially offset by a lower estimated effective tax rate for 2021.

      COVID-19 Update

      Bunge continues to take proactive steps to protect the health and safety of its employees, their families and the communities in which it operates. Through an internal task force, the Company closely monitors developments related to the pandemic and provides guidance to its facilities worldwide. Bunge is strongly encouraging its employees to be vaccinated when available in their countries, and facilitating this when possible.

      To date, the Company has been able to mitigate logistics and distribution issues that have arisen, and substantially all of its facilities around the world have continued to operate at or near normal levels. Bunge continues to monitor local, regional and national governmental actions that could limit or restrict the movement of agricultural commodities or products or otherwise disrupt physical product flows or its ability to operate in the future.

      Outlook

      We are increasing our full-year 2021 adjusted EPS outlook to at least $11.50 per share.

      In Agribusiness, results are expected to be up from our previous outlook and now forecasted to be higher than last year, reflecting our strong third quarter and favorable market trends.

      In Refined and Specialty Oils, results are expected to be up from our previous outlook and well above last year, reflecting strong third quarter results and positive demand trends in North America.

      We continue to expect results in Milling to be generally in line with last year.

      Excluding Bunge Ventures, Corporate and Other is expected to be lower than last year, driven by higher performance-based compensation, a portion of which was historically allocated to the segments.

      Additionally, the Company now expects the following for 2021: an adjusted annual effective tax rate in the range of 15% to 17%; net interest expense in the range of $200 to $210 million; capital expenditures in the range of $350 to $400 million; and depreciation and amortization of approximately $420 million.

      In Non-Core, full-year results in the sugar and bioenergy joint venture are now expected to be up significantly from the prior year.

      Conference Call and Webcast Details

      Bunge Limited’s management will host a conference call at 8:00 a.m. Eastern (7:00 a.m. Central) on Wednesday, October 27, 2021 to discuss the company’s results.

      Additionally, a slide presentation to accompany the discussion of results will be posted on www.bunge.com.

      To listen to the call, please dial 1 (844) 735-3666. If you are located outside the United States or Canada, dial +1 (412) 317-5706. Please dial in five to 10 minutes before the scheduled start time. The call will also be webcast live at www.bunge.com.

      To access the webcast, go to “Events and presentations” in the “Investors” section of the company’s website. Select “Q3 2021 Bunge Limited Earnings Conference Call” and follow the prompts. Please go to the website at least 15 minutes prior to the call to register and download any necessary audio software.

      A replay of the call will be available later in the day on October 27, 2021, continuing through November 27, 2021. To listen to it, please dial 1 (877) 344-7529 in the United States, 1 (855) 669-9658 in Canada, or +1 (412) 317-0088 in other locations. When prompted, enter confirmation code 10160167. A replay will also be available in "Past events" at "Events and presentations" in the "Investors" section of the company's website.

      About Bunge

      At Bunge (NYSE: BG), our purpose is to connect farmers to consumers to deliver essential food, feed and fuel to the world. With more than two centuries of experience, unmatched global scale and deeply rooted relationships, we work to put quality food on the table, increase sustainability where we operate, strengthen global food security, and help communities prosper. As the world’s leader in oilseed processing and a leading producer and supplier of specialty plant-based oils and fats, we value our partnerships with farmers to improve the productivity and environmental efficiency of agriculture across our value chains and to bring quality products from where they’re grown to where they’re consumed. At the same time, we collaborate with our customers to create and reimagine the future of food, developing tailored and innovative solutions to meet evolving dietary needs and trends in every part of the world. Our Company is headquartered in St. Louis, Missouri, and we have almost 23,000 dedicated employees working across approximately 300 facilities located in more than 40 countries.

      Website Information

      We routinely post important information for investors on our website, www.bunge.com, in the "Investors" section. We may use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investors section of our website, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

      Cautionary Statement Concerning Forward-Looking Statements

      This press release contains both historical and forward-looking statements. All statements, other than statements of historical fact are, or may be deemed to be, forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act). These forward looking statements are not based on historical facts, but rather reflect our current expectations and projections about our future results, performance, prospects and opportunities. We have tried to identify these forward looking statements by using words including “may,” “will,” “should,” “could,” “expect,” “anticipate,” “believe,” “plan,” “intend,” “estimate,” “continue” and similar expressions. These forward looking statements are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward looking statements. The following important factors, among others, could cause actual results to differ from these forward-looking statements: industry conditions, including fluctuations in supply, demand and prices for agricultural commodities and other raw materials and products used in our business, fluctuations in energy and freight costs; competitive developments in our industries; the effects of weather conditions and the outbreak of crop and animal disease on our business; global and regional economic, agricultural, financial and commodities market, political, social and health conditions; the impacts of pandemic outbreaks, including COVID-19; the outcome of pending regulatory and legal proceedings; our ability to complete, integrate and benefit from acquisitions, dispositions, joint ventures and strategic alliances; our ability to achieve the efficiencies, savings and other benefits anticipated from cost reduction, margin improvement, operational excellence and other business optimization initiatives; changes in government policies, laws and regulations affecting our business, including agricultural and trade policies and environmental, tax and biofuels regulation; our capital allocation plans, funding needs and financing sources; changes in foreign exchange policy or rates; the outcome of our portfolio rationalization initiatives; the effectiveness of our risk management strategies; our ability to attract and retain executive management and key personnel; operational risks, including industrial accidents, natural disasters and cybersecurity incidents; and other factors affecting our business generally. The forward-looking statements included in this release are made only as of the date of this release, and except as otherwise required by federal securities law, we do not have any obligation to publicly update or revise any forward-looking statements to reflect subsequent events or circumstances.

      Additional Financial Information

      Certain gains and (charges), quarter-to-date

      The following table provides a summary of certain gains and (charges) that may be of interest to investors, including a description of these items and their effect on net income (loss) attributable to Bunge, earnings per share diluted and segment EBIT for the three month periods ended September 30, 2021 and 2020.

      (US$ in millions, except per share data)

      Net Income (Loss)

      Attributable to

      Bunge

      Earnings

      Per Share

      Diluted

      Segment

      EBIT

      Quarter Ended September 30,

      2021

      2020

      2021

      2020

      2021

      2020

       

       

       

       

       

       

       

      Core Segments:

      $

      119

       

      $

       

      $

      0.78

       

      $

       

      $

      158

       

      $

       

       

       

       

       

       

       

       

      Agribusiness

      $

      119

       

      $

       

      $

      0.78

       

      $

       

      $

      158

       

      $

       

      Gain on sale of a business

      119

       

       

      0.78

       

       

      158

       

       

       

       

       

       

       

       

       

      Refined and Specialty Oil Products

      $

       

      $

       

      $

       

      $

       

      $

       

      $

       

       

       

       

       

       

       

       

      Milling Products

      $

       

      $

       

      $

       

      $

       

      $

       

      $

       

       

       

       

       

       

       

       

      Corporate and Other:

      $

       

      $

      21

       

      $

       

      $

      0.14

       

      $

       

      $

       

      Income tax benefits

       

      21

       

       

      0.14

       

       

       

       

       

       

       

       

       

       

      Non-core Segment:

      $

       

      $

       

      $

       

      $

       

      $

       

      $

       

       

       

       

       

       

       

       

      Sugar & Bioenergy

      $

       

      $

       

      $

       

      $

       

      $

       

      $

       

       

       

       

       

       

       

       

      Total

      $

      119

       

      $

      21

       

      $

      0.78

       

      $

      0.14

       

      $

      158

       

      $

       

       

       

       

       

       

       

       

      See Definition and Reconciliation of Non-GAAP Measures.

      Core Segments

      Agribusiness

      EBIT for the three months ended September 30, 2021 included a $158 million gain on sale of a portfolio of interior grain elevators located in the United States (U.S. Grain Disposition), recorded in Other income (expense) - net.

      Corporate and Other

      Net Income for the quarter ended September 30, 2020 included a $21 million benefit related to the reversal of a deferred tax asset valuation allowance in Europe.

      Certain gains and (charges), year-to-date

      The following table provides a summary of certain gains and (charges) that may be of interest to investors, including a description of these items and their effect on Net income (loss) attributable to Bunge, Earnings per share diluted and Segment EBIT for the nine month periods ended September 30, 2021 and 2020.

      (US$ in millions, except per share data)

      Net Income (Loss)

      Attributable to

      Bunge

      Earnings

      Per Share

      Diluted

      Segment

      EBIT

      Nine months ended September 30,

      2021

       

      2020

       

      2021

       

      2020

       

      2021

       

      2020

       

       

       

       

       

       

       

       

       

       

       

      Core Segments:

      $

      284

       

      $

       

      $

      1.86

       

      $

       

      $

      328

       

      $

       

       

       

       

       

       

       

       

       

       

       

      Agribusiness

      $

      119

       

      $

       

      $

      0.78

       

      $

       

      $

      158

       

      $

       

      Gain on sale of a business

      119

       

       

      0.78

       

       

      158

       

       

       

       

       

       

       

       

       

       

       

       

      Refined and Specialty Oil Products

      $

      165

       

      $

       

      $

      1.08

       

      $

       

      $

      170

       

      $

       

      Gain on sales of assets

      165

       

       

      1.08

       

       

      170

       

       

       

       

       

       

       

       

       

       

       

       

      Milling Products

      $

       

      $

       

      $

       

      $

       

      $

       

      $

       

       

       

       

       

       

       

       

       

       

       

      Corporate and Other:

      $

       

      $

      (48

      )

      $

       

      $

      (0.32

      )

      $

       

      $

      (71

      )

      Severance, employee benefit, and other costs

       

      (3

      )

       

      (0.02

      )

       

      (5

      )

      Commercial claim provision

       

      (66

      )

       

      (0.44

      )

       

      (66

      )

      Income tax benefits

       

      21

       

       

      0.14

       

       

       

       

       

       

       

       

       

       

       

       

       

      Non-core Segment:

      $

       

      $

       

      $

       

      $

       

      $

       

      $

       

       

       

       

       

       

       

       

       

       

       

      Sugar & Bioenergy

      $

       

      $

       

      $

       

      $

       

      $

       

      $

       

       

       

       

       

       

       

       

       

       

       

      Total

      $

      284

       

      $

      (48

      )

      $

      1.86

       

      $

      (0.32

      )

      $

      328

       

      $

      (71

      )

       

       

       

       

       

       

       

       

       

       

      See Definition and Reconciliation of Non-GAAP Measures.

      Core Segments

      Agribusiness

      EBIT for the nine months ended September 30, 2021 included a $158 million gain on sale of a portfolio of interior grain elevators located in the United States (U.S. Grain Disposition), recorded in Other income (expense) - net.

      Refined and Specialty Oil Products

      EBIT for the nine months ended September 30, 2021 included $170 million in gains on sales of assets, comprised of a $151 million gain on sale of our Rotterdam Oils Refinery, at Bunge's 70% share, and a $19 million gain on sale of an oils packaging facility in Mexico, both recorded in Other income (expense) - net.

      Corporate and Other

      EBIT for the nine month period ended September 30, 2020 included a $66 million charge primarily related to a provision against an aged receivable that in the nine months ended September 30, 2020 became deemed uncollectible as part of an anticipated legal settlement. For this matter $51 million was recorded in SG&A and $15 million was recorded in Other income (expense) - net. EBIT for the nine month period ended September 30, 2020 also included $5 million of charges related to the relocation of Bunge’s global headquarters from White Plains, New York to St. Louis, Missouri, included in SG&A. Net Income for the nine month period ended September 30, 2020 included a $21 million benefit related to the reversal of a deferred tax asset valuation allowance in Europe.

      Consolidated Earnings Data (Unaudited)

         

        Quarter Ended
        September 30,

         

        Nine Months Ended
        September 30,

        (US$ in millions, except per share data)

        2021

         

        2020

         

         

        2021

         

        2020

         

        Net sales

        $

        14,117

         

        $

        10,159

         

         

        $

        42,469

         

        $

        28,794

         

        Cost of goods sold

        (13,255

        )

        (9,557

        )

         

        (39,795

        )

        (26,913

        )

        Gross profit

        862

         

        602

         

         

        2,674

         

        1,881

         

        Selling, general and administrative expenses

        (327

        )

        (352

        )

         

        (896

        )

        (993

        )

        Foreign exchange (losses) gains

        (36

        )

        54

         

         

        (11

        )

        75

         

        Other income (expense) – net

        220

         

        17

         

         

        519

         

        37

         

        Income (loss) from affiliates

        60

         

        35

         

         

        133

         

        (76

        )

        EBIT attributable to noncontrolling interest (a) (1)

        5

         

        (5

        )

         

        (90

        )

        (5

        )

        Total Segment EBIT

        784

         

        351

         

         

        2,329

         

        919

         

        Interest income

        19

         

        5

         

         

        34

         

        18

         

        Interest expense

        (57

        )

        (56

        )

         

        (184

        )

        (195

        )

        Income tax (expense) benefit

        (92

        )

        (38

        )

         

        (334

        )

        (151

        )

        Noncontrolling interest share of interest and tax (a) (1)

        (1

        )

         

         

        2

         

        3

         

        Net income (loss) attributable to Bunge (1)

        653

         

        262

         

         

        1,847

         

        594

         

        Convertible preference share dividends

        (8

        )

        (8

        )

         

        (25

        )

        (25

        )

        Adjustment of redeemable noncontrolling interest

         

        12

         

         

         

        2

         

        Net income (loss) available to Bunge common shareholders

        $

        645

         

        $

        266

         

         

        $

        1,822

         

        $

        571

         

        Add back convertible preference share dividends

        8

         

        8

         

         

        25

         

        25

         

        Net income (loss) available to Bunge common shareholders - diluted

        $

        653

         

        $

        274

         

         

        $

        1,847

         

        $

        596

         

         

         

         

         

         

         

        Net income (loss) per common share diluted attributable to Bunge common shareholders

        $

        4.28

         

        $

        1.84

         

         

        $

        12.12

         

        $

        3.98

         

        Weighted–average common shares outstanding - diluted

        153

         

        149

         

         

        152

         

        150

         

         

         

         

         

         

         

        (a) The line items "EBIT attributable to noncontrolling interest" and "Noncontrolling interest share of interest and tax" when combined, represent consolidated Net (income) loss attributable to noncontrolling interests on a U.S. GAAP basis of presentation.

        Condensed Consolidated Balance Sheets (Unaudited)

           

          September 30,

           

          December 31,

          (US$ in millions)

          2021

           

          2020

          Assets

           

           

           

          Cash and cash equivalents

          $

          1,033

           

           

          $

          352

           

          Trade accounts receivable, net

          2,431

           

           

          1,717

           

          Inventories (a)

          8,014

           

           

          7,172

           

          Assets held for sale

           

           

          672

           

          Other current assets

          5,056

           

           

          6,268

           

          Total current assets

          16,534

           

           

          16,181

           

          Property, plant and equipment, net

          3,658

           

           

          3,775

           

          Operating lease assets

          910

           

           

          868

           

          Goodwill and other intangible assets, net

          1,044

           

           

          1,115

           

          Investments in affiliates

          755

           

           

          631

           

          Other non-current assets

          1,208

           

           

          1,085

           

          Total assets

          $

          24,109

           

           

          $

          23,655

           

           

           

           

           

          Liabilities and Equity

           

           

           

          Short-term debt

          $

          1,151

           

           

          $

          2,828

           

          Current portion of long-term debt

          510

           

           

          8

           

          Trade accounts payable

          3,944

           

           

          2,636

           

          Current operating lease obligations

          332

           

           

          235

           

          Liabilities held for sale

           

           

          438

           

          Other current liabilities

          3,822

           

           

          4,840

           

          Total current liabilities

          9,759

           

           

          10,985

           

          Long-term debt

          4,814

           

           

          4,452

           

          Non-current operating lease obligations

          522

           

           

          581

           

          Other non-current liabilities

          980

           

           

          1,017

           

          Total liabilities

          16,075

           

           

          17,035

           

          Redeemable noncontrolling interest

          403

           

           

          415

           

          Total equity

          7,631

           

           

          6,205

           

          Total liabilities, redeemable noncontrolling interest and equity

          $

          24,109

           

           

          $

          23,655

           

          (a) Includes readily marketable inventories of $6,505 million and $5,961 million at September 30, 2021 and December 31, 2020, respectively. Of these amounts, $4,956 million and $4,369 million, respectively, can be attributable to merchandising activities.

          Condensed Consolidated Statements of Cash Flows (Unaudited)

             

            Nine Months Ended

            September 30,

            (US$ in millions)

            2021

            2020

            Operating Activities

             

             

            Net income (loss) (1)

            $

            1,935

             

            $

            596

             

            Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:

             

             

            Foreign exchange (gain) loss on net debt

            7

             

            (126

            )

            Depreciation, depletion and amortization

            317

             

            323

             

            Deferred income tax expense (benefit)

            (263

            )

            51

             

            (Gain) loss on sale of investments and property, plant and equipment

            (416

            )

            (19

            )

            Other, net

            (55

            )

            204

             

            Changes in operating assets and liabilities, excluding the effects of acquisitions:

             

             

            Trade accounts receivable

            (785

            )

            (237

            )

            Inventories

            (771

            )

            (1,679

            )

            Secured advances to suppliers

            (42

            )

            (296

            )

            Trade accounts payable and accrued liabilities

            1,268

             

            260

             

            Advances on sales

            (129

            )

            (119

            )

            Net unrealized (gain) loss on derivative contracts

            559

             

            173

             

            Margin deposits

            280

             

            (360

            )

            Marketable securities

            (95

            )

            98

             

            Beneficial interest in securitized trade receivables

            (3,621

            )

            (1,178

            )

            Other, net

            169

             

            181

             

            Cash provided by (used for) operating activities

            (1,642

            )

            (2,128

            )

            Investing Activities

             

             

            Payments made for capital expenditures

            (239

            )

            (230

            )

            Proceeds from investments

            171

             

            270

             

            Payments for investments

            (217

            )

            (293

            )

            Settlement of net investment hedges

            (29

            )

            67

             

            Proceeds from beneficial interest in securitized trade receivables

            3,432

             

            1,164

             

            Payments for beneficial interest in securitized trade receivables

            (177

            )

             

            Proceeds from the sale of investments and property, plant and equipment

            646

             

            15

             

            Payments for investments in affiliates

            (46

            )

            (14

            )

            Other, net

            21

             

            1

             

            Cash provided by (used for) investing activities

            3,562

             

            980

             

            Financing Activities

             

             

            Net borrowings (repayments) of short-term debt

            (1,641

            )

            683

             

            Net proceeds (repayments) of long-term debt

            998

             

            796

             

            Proceeds from the exercise of options for common shares

            72

             

            2

             

            Repurchases of common shares

            (100

            )

            (100

            )

            Dividends paid to common and preference shareholders

            (240

            )

            (237

            )

            Dividends paid to noncontrolling interest holders

            (75

            )

             

            Acquisition of noncontrolling interest

            (147

            )

             

            Other, net

            (33

            )

            (15

            )

            Cash provided by (used for) financing activities

            (1,166

            )

            1,129

             

            Effect of exchange rate changes on cash and cash equivalents and restricted cash

            (79

            )

            5

             

            Net increase (decrease) in cash and cash equivalents and restricted cash

            675

             

            (14

            )

            Cash and cash equivalents and restricted cash - beginning of period

            381

             

            322

             

            Cash and cash equivalents and restricted cash - end of period

            $

            1,056

             

            $

            308

             

            Definition and Reconciliation of Non-GAAP Measures

            This earnings release contains certain "non-GAAP financial measures" as defined in Regulation G of the Securities Exchange Act of 1934. Bunge has reconciled these non-GAAP financial measures to the most directly comparable U.S. GAAP measures below. These measures may not be comparable to similarly titled measures used by other companies.

            Total Segment EBIT and Adjusted Total Segment EBIT

            Bunge uses segment earnings before interest and tax (“Segment EBIT”) to evaluate the operating performance of its individual segments. Segment EBIT excludes EBIT attributable to noncontrolling interests. Bunge also uses Core Segment EBIT, Non-Core Segment EBIT and Total Segment EBIT to evaluate the operating performance of Bunge’s Core reportable segments, Non-Core reportable segments, and Total reportable segments together with its corporate and other activities, respectively. Core Segment EBIT is the aggregate of the earnings before interest and taxes of each of Bunge’s Agribusiness, Refined and Specialty Oils, and Milling segments. Non-Core Segment EBIT is the earnings before interest and taxes of Bunge’s Sugar & Bioenergy segment. Total Segment EBIT is the aggregate of the earnings before interest and taxes of Bunge’s Core and Non-Core reportable segments, together with its corporate and other activities.

            Adjusted Core Segment EBIT, Adjusted Non-Core Segment EBIT, and Adjusted Total Segment EBIT, are calculated by excluding temporary mark-to-market timing differences, as defined in note 3 below, and certain gains and (charges), as described in "Additional Financial Information" above, from Core Segment EBIT, Non-Core Segment EBIT, and Total Segment EBIT, respectively.

            Core Segment EBIT, Non-Core Segment EBIT, Total Segment EBIT, Adjusted Core Segment EBIT, Adjusted Non-Core Segment EBIT, and Adjusted Total Segment EBIT are non-GAAP financial measures and are not intended to replace Net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. Bunge's management believes these non-GAAP measures are a useful measure of its reportable segments' operating profitability, since the measures allow for an evaluation of segment performance without regard to their financing methods or capital structure. For this reason, operating performance measures such as these non-GAAP measures are widely used by analysts and investors in Bunge's industries. These non-GAAP measures are not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to net income (loss) or any other measure of consolidated operating results under U.S. GAAP.

            Net Income (loss) attributable to Bunge to Adjusted Net Income (loss) available for common shareholders

            Adjusted Net Income (loss) excludes temporary mark-to-market timing differences, as defined in note 3 below, and certain gains and (charges), as described in "Additional Financial Information" above, and is a non-GAAP financial measure. This measure is not a measure of Net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. It should not be considered as an alternative to Net Income (loss) attributable to Bunge, Net Income (loss), or any other measure of consolidated operating results under U.S. GAAP. Adjusted Net income (loss) is a useful measure of the Company's profitability.

            We also have presented projected adjusted net income per common share for 2021. This information is provided only on a non-GAAP basis without reconciliation to projected net income per common share for 2021, the mostly directly comparable GAAP measure, due to the inability at this time to quantify certain amounts necessary for such reconciliation, including but not limited to future market price movements over the remainder of the year.

            Below is a reconciliation of Net income attributable to Bunge, to Total Segment EBIT, and Adjusted Total Segment EBIT:

               

              Quarter Ended

              September 30,

               

              Nine Months Ended

              September 30,

              (US$ in millions)

              2021

               

              2020

               

              2021

               

              2020

              Net income (loss) attributable to Bunge

              $

              653

               

               

              $

              262

               

               

              $

              1,847

               

               

              $

              594

               

              Interest income

              (19

              )

               

              (5

              )

               

              (34

              )

               

              (18

              )

              Interest expense

              57

               

               

              56

               

               

              184

               

               

              195

               

              Income tax expense (benefit)

              92

               

               

              38

               

               

              334

               

               

              151

               

              Noncontrolling interest share of interest and tax

              1

               

               

               

               

              (2

              )

               

              (3

              )

              Total Segment EBIT

              $

              784

               

               

              $

              351

               

               

              $

              2,329

               

               

              $

              919

               

               

               

               

               

               

               

               

               

              Agribusiness EBIT

              $

              639

               

               

              $

              317

               

               

              $

              1,838

               

               

              $

              1,069

               

              Refined and Specialty Oils EBIT

              130

               

               

              76

               

               

              541

               

               

              $

              174

               

              Milling EBIT

              43

               

               

              26

               

               

              85

               

               

              $

              69

               

              Core Segment EBIT

              $

              812

               

               

              $

              419

               

               

              $

              2,464

               

               

              $

              1,312

               

               

               

               

               

               

               

               

               

              Corporate and Other EBIT

              $

              (81

              )

               

              $

              (92

              )

               

              $

              (227

              )

               

              $

              (279

              )

               

               

               

               

               

               

               

               

              Sugar & Bioenergy EBIT

              $

              53

               

               

              $

              24

               

               

              $

              92

               

               

              $

              (114

              )

              Non-Core Segment EBIT

              $

              53

               

               

              $

              24

               

               

              $

              92

               

               

              $

              (114

              )

               

               

               

               

               

               

               

               

              Total Segment EBIT

              $

              784

               

               

              $

              351

               

               

              $

              2,329

               

               

              $

              919

               

              Mark-to-market timing difference

              44

               

               

              161

               

               

              (151

              )

               

              186

               

              Certain (gains) & charges

              (158

              )

               

               

               

              (328

              )

               

              71

               

              Adjusted Total Segment EBIT

              $

              670

               

               

              $

              512

               

               

              $

              1,850

               

               

              $

              1,176

               

               

               

               

               

               

               

               

               

              Below is a reconciliation of Net income attributable to Bunge, to Adjusted Net income (loss) available for common shareholders:

               

              Quarter Ended

              September 30,

               

              Nine Months Ended

              September 30,

              (US$ in millions, except per share data)

              2021

               

              2020

               

              2021

               

              2020

              Net income (loss) attributable to Bunge

              $

              653

               

               

              $

              262

               

               

              $

              1,847

               

               

              $

              594

               

              Mark-to-market timing difference

              33

               

               

              126

               

               

              (126

              )

               

              146

               

              Certain (gains) and charges:

               

               

               

               

               

               

               

              Severance, employee benefit, and other

               

               

               

               

               

               

              3

               

              Commercial claim provision

               

               

               

               

               

               

              66

               

              Gain on sales of assets

               

               

               

               

              (165

              )

               

               

              Gain on sale of a business

              (119

              )

               

               

               

              (119

              )

               

               

              Income tax benefits

               

               

              (21

              )

               

               

               

              (21

              )

              Adjusted Net income (loss) available for common shareholders

              $

              567

               

               

              $

              367

               

               

              $

              1,437

               

               

              $

              788

               

              Weighted-average common shares outstanding - diluted, adjusted (a)

              153

               

               

              149

               

               

              152

               

               

              150

               

              Adjusted Net income (loss) per common share - diluted

              $

              3.72

               

               

              $

              2.47

               

               

              $

              9.43

               

               

              $

              5.26

               

              (a) Approximately 2 and 6 million outstanding stock options and contingently issuable restricted stock units were not dilutive and not included in the weighted-average number of common shares outstanding for the three months ended September 30, 2021 and 2020, respectively. Approximately 2 million and 6 million outstanding stock options and contingently issuable restricted stock units were not dilutive and not included in the weighted-average number of common shares outstanding for the nine months ended September 30, 2021 and 2020, respectively.

              Notes

                (1)

                 

                A reconciliation of Net income (loss) attributable to Bunge, to Net income (loss) is as follows:

                 

                Nine months ended September 30,

                (US$ in millions)

                2021

                 

                2020

                Net income (loss) attributable to Bunge

                $

                1,847

                 

                 

                $

                594

                 

                EBIT attributable to noncontrolling interest

                90

                 

                 

                5

                 

                Noncontrolling interest share of interest and tax

                (2)

                 

                 

                (3)

                 

                Net income (loss)

                $

                1,935

                 

                 

                $

                596

                 

                (2)

                 

                The Processing business included in our Agribusiness segment consists of: global oilseed processing activities, which principally include the origination and crushing of oilseeds (including soybeans, canola, rapeseed and sunflower seed) into protein meals and vegetable oils; the distribution of oilseeds, oilseed products and fertilizer products through our port terminals and transportation assets (including trucks, railcars, barges and ocean vessels); fertilizer production; and biodiesel production, which is partially conducted through joint ventures.

                 

                 

                The Merchandising business included in our Agribusiness segment primarily consists of: global grain origination activities, which principally include the purchasing, cleaning, drying, storing and handling of corn, wheat and barley at our network of grain elevators; logistical services for the distribution of these commodities to our customer markets through our port terminals and transportation assets (including trucks, railcars, barges and ocean vessels); and financial services and activities for customers from whom we purchase commodities, and other third parties.

                (3)

                 

                Mark-to-market timing difference comprises the estimated net temporary impact resulting from unrealized period-end gains/losses associated with the fair valuation of certain forward contracts, readily marketable inventories (RMI), and related futures contracts associated with our committed future operating capacity. The impact of these mark-to-market timing differences, which is expected to reverse over time due to the forward contracts, RMI, and related futures contracts being part of an economically-hedged position, is not representative of the operating performance of our business.

                (4)

                 

                In the reconciliation of Net income (loss) per common share - diluted ("GAAP EPS") to Adjusted Net income (loss) per common share - diluted ("Adjusted EPS"), the item "Adjustment of redeemable noncontrolling interest" represents the impact on GAAP EPS of a retained earnings adjustment associated with the carrying amount of the redeemable noncontrolling interest recorded in respect of our 70% ownership interest in Loders. The carrying amount of redeemable noncontrolling interests is the greater of: (i) the initial carrying amount, increased or decreased for the noncontrolling interests’ share of net income or loss, equity capital contributions and distributions or (ii) the redemption value. Any resulting increases in the redemption value, in excess of the initial carrying amount, increased or decreased for the noncontrolling interests’ share of net income or loss, equity capital contributions and distributions, are affected by corresponding charges against retained earnings. Additionally, any such charges to retained earnings will affect Net income (loss) available to Bunge common shareholders as part of Bunge's calculation of GAAP EPS.

                 

                 

                Bunge's management excludes the “Adjustment of redeemable noncontrolling interest" from its calculation of Adjusted EPS, on the basis that it is independent of the Company's operations. However, such charges reverse only to the extent that Loders' net income levels result in the carrying amount of redeemable noncontrolling interests, calculated as described above, exceeding the redemption value.

                (5)

                 

                A reconciliation of Cash provided by (used for) operating activities to Adjusted funds from operations (FFO) is as follows:

                   

                 

                Nine months ended September 30,

                   

                (US$ in millions)

                2021

                 

                2020

                   

                Cash provided by (used for) operating activities​

                $

                (1,642)

                 

                 

                $

                (2,128)

                 

                   

                Foreign exchange gain (loss) on net debt​

                (7)

                 

                 

                126

                 

                   

                Working capital changes​

                3,167

                 

                 

                3,157

                 

                   

                Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests​

                (88)

                 

                 

                (2)

                 

                   

                Mark-to-Market timing difference, after tax​

                (126)

                 

                 

                146

                 

                   

                Adjusted FFO

                $

                1,304

                 

                 

                $

                1,299

                 

                 

                Sign Up To Get Daily Green Stock News In Your Inbox

                Please review our Disclaimer and Privacy Policy before subscribing.
                Northstar Clean Technologies

                Northstar Clean Technologies is a cleantech company focused on the sustainable recovery and reprocessing of asphalt shingles. Northstar’s mission is to be the leader in the recovery and reprocessing of asphalt shingles in North America...

                CLICK TO LEARN MORE
                Else Nutrition

                Else Nutrition is changing the face of early childhood nutrition with clean, sustainable, plant-based products. The company has developed the world’s first whole plant-based infant formula that is targeting the $100+ billion global...

                CLICK TO LEARN MORE

                COPYRIGHT ©2022 GREEN STOCK NEWS